Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Galderma Investigational Site
Barrie, Ontario, Canada
- Galderma Investigational Site
North Bay, Ontario, Canada
- Galderma Investigational Site
Windsor, Ontario, Canada
- Galderma Investigational Site
Québec, Quebec, Canada
- Galderma Investigational Site
Aibonito, Puerto Rico
- Galderma Investigational Site
Carolina, Puerto Rico
- Galderma Investigational Site
San Diego, California, United States
- Galderma Investigational Site
Denver, Colorado, United States
- Galderma Investigational Site
Longmont, Colorado, United States
- Galderma Investigational Site
Miami, Florida, United States
- Galderma Investigational Site
Snellville, Georgia, United States
- Galderma Investigational Site
Chicago, Illinois, United States
- Galderma Investigational Site
Evansville, Indiana, United States
- Galderma Investigational Site
Overland Park, Kansas, United States
- Galderma Investigational Site
Louisville, Kentucky, United States
- Galderma Investigational Site
Detroit, Michigan, United States
- Galderma Investigational Site
Fort Gratiot, Michigan, United States
- Galderma Investigational Site
Fridley, Minnesota, United States
- Galderma Investigational Site
Omaha, Nebraska, United States
- Galderma Investigational Site
Albuquerque, New Mexico, United States
- Galderma Investigational Site
Stony Brook, New York, United States
- Galderma Investigational Site
Winston-Salem, North Carolina, United States
- Galderma Investigational Site
Warren, Ohio, United States
- Galderma Investigational Site
Hazleton, Pennsylvania, United States
- Galderma Investigational Site
Hershey, Pennsylvania, United States
- Galderma Investigational Site
Simpsonville, South Carolina, United States
- Galderma Investigational Site
Arlington, Texas, United States
- Galderma Investigational Site
Austin, Texas, United States
- Galderma Investigational Site
College Station, Texas, United States
- Galderma Investigational Site
Houston, Texas, United States
- Galderma Investigational Site
Lubbock, Texas, United States
- Galderma Investigational Site
San Antonio, Texas, United States
- Galderma Investigational Site
Webster, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2008
- Primary completion
- 31 Jul 2009
- Completion
- 31 Jul 2009
- Last update posted
- 18 Feb 2021
- Registered enrollment
- 243
- Registry id
- NCT00687908
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.